Yongzhi Zhuang

SRPX2 Enhances the Epithelial–Mesenchymal Transition and Temozolomide Resistance in Glioblastoma Cells

Haitao Tang, Jiaxin Zhao, Liangyu Zhang et al. · Cellular and Molecular Neurobiology · 2015 · 52 citations · Full text

Medicine, Cancer Biology, Oncology +16

LncRNA PTCSC3 Is a Biomarker for the Treatment and Prognosis of Gastric Cancer

Guodong Zhang, Nannan Chi, Qingfeng Lu et al. · Cancer Biotherapy and Radiopharmaceuticals · 2019 · 42 citations

Medicine, Molecular Biology, Oncology +17

Real‐world <i>EGFR</i> testing in patients with stage IIIB/IV non‐small‐cell lung cancer in North China: A multicenter, non‐interventional study

Ying Cheng, Yan Wang, Jun Zhao et al. · Thoracic Cancer · 2018 · 36 citations · Full text

Medicine, Oncology, Pharmacology +16

Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional study

Jianqiu Wu, Yongping Song, Liping Su et al. · BMC Cancer · 2016 · 32 citations · Full text

Medicine, Hematology, Oncology +10

Three-year Follow-up on the Safety and Effectiveness of Rituximab Plus Chemotherapy as First-Line Treatment of Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in Real-World Clinical Settings in China

Jianqiu Wu, Yongping Song, Liping Su et al. · Chinese Medical Journal · 2018 · 27 citations · Full text

Medicine, Hematology, Oncology +16